J35.0
Conditions
Interventions
Group 1: new tonsillectomy technique (with mucosal flap), either experienced senior physician or a resident as surgeon under supervision
Group 2: conventional tonsillectomy technique (without mucosal
Sponsors
Universitätsklinikum des Saarlandes Klinik für HNO-Heilkunde
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age > or = 18 years; chronic tonsillitis with at least 3 reported acute episodes of tonsillitis treated with antibiotics during one year; foetor ex ore; peritonsillar abscess in history
Exclusion criteria
Exclusion criteria: age < 18 years; no history of chronic Tonsillitis with at least 3 episodes of acute Tonsillitis treated with antibiotics in one year; no foetor ex ore; no peritonsillar bascess in history; chronic Treatment with anticoagulatory drugs or inhibitors of thrombocyte fundtion; allergic reaction against one of the Standard pain medication used in this study (Celecoxib + Tapentadol); necessary Change of postoperative pain medication due to adverse effects of the standard medication; hereditary coagulation disorders; chronic pain syndrome with permanent pain medication; additional surgical procedures beneath tonsillectomy during the same Operation, e.g. adenotomy or panendoscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pain (questionnaire for the patients for the first 10 postoperative days, numerical analogue scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| risk of postoperative bleeding (statistical documentation); edema (semiquantitative registration by the treating physician); general condition (numerical analogue scale); swallowing (numerical analogue scale); speech (numerical analogue scale); need for analgetics (documented for the time span of the patient's stay in clinic) | — |
Countries
Germany
Contacts
Public ContactMaximilian Linxweiler
Universitätsklinikum des Saarlandes Klinik für HNO-Heilkunde
Outcome results
None listed